Abstract
In the treatment of cerebral infarction, it is of course important to distinguish between the prevention and the treatment of the underlying lesions which give rise to cerebral infarction, but in clinical practice the basis for treatment normally focuses on two problems: how to minimize cerebral edema and how to prevent progression of the lesion to a state of infarction. For these purposes, various drug therapies have been developed, but there are as yet few techniques which have been shown to be theoretically and experimentally sound and clinically effective. In practice, it is therefore necessary first to come to a sufficient understanding of the changing cerebral pathology of each patient, and then to undertake control of blood pressure, cerebral edema, etc., in order to maintain appropriate cerebral blood flow and control of the patient's systemic condition.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Acheson J (1971): Factors affecting the natural history of focal cerebral vascular disease. Q J Med 40: 25–46
Baker RN, Broward JH, pang HC et al (1962): Anticoagulant therapy in cerebral infarction: report of a co-operative study. Neurology (Minneap) 12: 823–835
Baskin DS, Hosobuchi Y (1981): Naloxone reversal of ischemic neurological deficits in man. Lancet 2: 272–275
Beevers DG, Fairman MJ, Hamilton M et al (1973): Antihypertensive treatment and the course of established cerebral disease. Lancet 1: 1407–1409
Bousser MG, Eschwege E, Hauenau M et al (1983) AICLA“controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia. Stroke 14: 5–14
Canadian Cooperative Study Group (1978): A randomized trial of aspirin and sul-flnphrazone in threatened stroke. N Engl J Med 299: 53–59
Carter AB (1961): Anticoagulant treatment in progressing stroke. Br Med J 52: 70–73
Carter AB (1970): Hypotensive therapy in stroke survivors. Lancet 1: 485–489
Dyken M, White PT (1956): Evaluation of cortisone in treatment of cerebral infarction. JAMA 162: 1531–1534
Fields W, Lemak NA, Frankowski RF et al (1977): Controlled trial of aspirin in cerebral ischemia. Stroke 8: 301–316
Fisher CM (1982): Management of occlusive cerebrovascular disease. In: Ropper AH, Kennedy SK et al (eds) Neurological and neurosurgical intensive care. University Park Press, Baltimore, pp 189–205
Fletcher AP, Alkjaersig N, Lewis M et al (1976): A pilot study of urokinase therapy in cerebral infarction. Stroke 7: 135–142
Harter HR, Burch N, Majerus PW et al (1979): Prevention of thrombosis in patients on hemodialysis by low-dose aspirin. N Engl J Med 301: 577–579
Heck AF (1984): Medical management of TIAs and small strokes. In: Smith RR (ed): Stroke and the extracranial vessels. Raven Press, New York’ pp 149–158
Hutchinson EC (1983): Management of cerebral infarction. In: Russel RWR (ed) Vascular disease of the central nervous system, edn 2, Churchill Livingstone, Edinburgh London Melbourne New York, pp 185–203
Genton E, Barnett HJM, Fields WS et al (1977): Cerebral ischemia: The role of thrombosis and of antithrombotic therapy. Stroke 8: 150–175
Katzman R, Clasen R, Klatzo I et al (1977): Brain edema in stroke. Stroke 8: 512–540
Kuriyama Y, Sawada T, Yamaguchi T et al (1980): Induced hemodilution in acute stage of cerebral infarction, its pathophysiological and therapeutic consideration. Jpn J Stroke 2: 309–315 (Eng Abstr)
Matthews WB, Oxbury JM, Grainger KMR et al (1976): A blind controlled trial of dextran 40 in the treatment of ischemic stroke. Brain 99: 193–206
Meyer JS, Charney JZ, Mathew NT (1971): Treatment with glycerol of cerebral edema due to acute cerebral infarction. Lancet 2: 993–997
Meyer JS, Fukuuchi Y, Shimazu J et al (1972): Effect of intravenous infusion of glycerol on hemispheric blood flow and metabolism in patients with acute cerebral infarction. Stroke 3: 167–180
Meyer JS, Gilroy JG, Barnhart MI et al (1963): Therapeutic thrombosis in cerebral thromboembolism. Neurology 13: 927–937
Millikan CH (1971): Reassessment of anticoagulant therapy in various types of occlusive cerebrovascular disease. Stroke 2: 201–208
Minematsu K, Yamaguchi T, Kuryama Y et al (1983): Clinical application of barbiturate therapy for cerebral infarction: a preliminary report. Jpn J Stroke 5: 286–294
Mizoi M, Oba M, Fujimoto S et al (1984): An experimental study on the protective effect of nizofenone in cerebral ischemia. No To Shinkei 36: 1089–1093
Mulley G, Wilcox RG, Mitchell JRA (1978): Dexamethasone in acute stroke. Br Med J 2: 994–996
Patten BM, Mendell J, Bruun B et al (1972): Doubleblind study of the effects of dexamethasone on acute stroke. Neurology 22: 337–383
Rockoff MA, Marshall LF, Shapiro HM (1979): High-dose barbiturate therapy in humans: a clinical review of 60 patients. Ann Neurol 6: 194–199
Sandok BA, Furlan AJ, Whisnant JP et al (1978): Guidelines for the management of transient ischemic attacks. Mayo Clin Proc 53: 665–674
Satake K, Kondo H, Fukase M (1979): A double-blind study on the clinical efficacy of urokinase in treatment of patients with cerebral infarction. In: Yamori et al (eds) Prophylactic approach to hypertensive disease. Perspective in Cardiovascular Reseach 4: 433–440
Smith AL, Hoff JT, Nielsen SL et al (1974) Barbiturate protection in acute focal cerebral ischemia. Stroke 5: 1–5
Smith AL (1977) Barbiturate protection in cerebral hypoxia. Anesthesiology 47: 285–293
Sorensen PS, Pedersen H, Marquardsen J et al (1983) Acetylsalicylic acid in the prevention of stroke in patients with reversible cerebral ischemic attacks: a Danich cooperative study. Stroke 14: 15–22
Suzuki J, Fujimoto S, Mizoi K et al (1984) The protective effect of combined administration of anti-oxidants and perfluorochemicals on cerebral ischemia. Stroke 15: 672–679
Suzuki TA, Yoshimoto T et al (1985) Use of balloon occlusion and substances to protect ischemic brain during resection of posterior fossa AVM: case report. J Neurosurg 63: 626–629
Tamura A, Asano T, Sano K et al (1979) Protection from cerebral ischemia by a new imidazole derivative (Y-9179) and pentobarbital: a comparative study in chronic MCA occlusion in cats. Stroke 10: 126–134
Yatsu FM, Diamond I, Graziano C et al (1972) Experimental brain ischemia: protection from irreversible damage with a rapid-acting barbiturate (methohexital). Stroke 3: 726–732
Yatsu FM (1975) Protective effects of barbiturates on cerebral ischemia. In: McLaurin RL (ed) Head injuries, 2nd Chicago Symposium on Neural Trauma. Grune and Stratton, New York, pp 185–187
Yatsu FM (1984) Medical management of complete strokes. In: Smith RR (ed) Stroke and the extracranial vessels. Raven Press, New York, pp 159–166
Whisnant JP, Matsumoto N, Elveback LR (1973) The effect of anticoagulation therapy on the prognosis of patients with transient cerebral ischemic attacks in a community: Rochester, Minnesota 1955 through 1969. Mayo Clin Proc 48: 844–848
Wise BL, Chater N (1962) The value of hypertonic mannitol solution in decreasing brain mass and lowering cerebrospinal fluid pressure. J Neurosurg 19: 1038–1043
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1987 Springer-Verlag/Wien
About this chapter
Cite this chapter
Suzuki, J. (1987). Medical Treatment of Cerebral Infarction. In: Treatment of Cerebral Infarction. Springer, Vienna. https://doi.org/10.1007/978-3-7091-8861-3_10
Download citation
DOI: https://doi.org/10.1007/978-3-7091-8861-3_10
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-8863-7
Online ISBN: 978-3-7091-8861-3
eBook Packages: Springer Book Archive